The Karnataka Special Investigation Team (SIT) is questioning Veeresh Kumar Jain, the alleged kingpin of a counterfeit pharmaceuticals racket, and has established that he reportedly ran a network supplying fake tablets, syrups, and other medicines to more than 80 medical shops and private hospitals across the state. Jain was taken into custody on Sunday, 14 September 2026, following raids on his properties, and investigators estimate the racket generated an annual turnover of more than ₹15 crore.

How the Racket Allegedly Operated

According to investigators, Jain allegedly directed an associate identified as Prashant and others in managing day-to-day operations of the counterfeit medicine supply chain. The network reportedly sourced medicines, repackaged them, and distributed the spurious products to unsuspecting medical shops and private hospitals. Counterfeit medicines were allegedly supplied to several outlets in Bengaluru, raising serious concerns over patient safety — particularly for those who may have already consumed the spurious drugs.

The investigation traces the origin of the racket to a facility unearthed roughly two weeks ago in Dodderi on the outskirts of Bengaluru in Ramanagara district. One of the more alarming findings, according to investigators, is a reported international connection: counterfeit labels were allegedly sourced from foreign locations before being applied to the repackaged medicines.

Multi-State Raids Across Six States

In a coordinated operation, the SIT and the Drugs Control Department conducted raids at 10 locations spanning Karnataka, Haryana, Maharashtra, Tamil Nadu, Himachal Pradesh, and Telangana on Friday. Approximately 80 to 100 officials and staff members took part in the searches, targeting offices, premises, and properties linked to companies allegedly involved in manufacturing, repackaging, and supplying counterfeit medicines.

In Bengaluru, a pharmaceutical company's premises at Minerva Circle near Lalbagh was searched as part of the probe. Officials are currently examining medicines allegedly sourced from multiple locations and subsequently repackaged or routed through the distribution network.

Financial Trail and Wider Network Under Scrutiny

The SIT is pressing Jain for details on financial transactions and the identities of other individuals embedded in the racket. Investigators are working to identify additional participants based on disclosures made during his questioning. The probe is examining the full supply chain — covering the sources of counterfeit medicines, manufacturing and repackaging facilities, and the end-point distributors, including shops and hospitals that allegedly received the supplies.

This is a developing investigation, and the full scale of the network — including the role of private hospitals that may have knowingly or unknowingly stocked counterfeit medicines — is yet to be determined.

Implications for Public Health

The alleged distribution of fake medicines to more than 80 medical outlets across Karnataka raises acute public health concerns. Counterfeit pharmaceuticals can be ineffective at best and actively harmful at worst, particularly for patients managing chronic or acute conditions. Health officials have not yet issued a public recall or advisory, but the SIT's findings are expected to inform regulatory action by the Drugs Control Department. The case is being closely watched as a test of how swiftly the state's health and law enforcement apparatus can contain a supply-chain breach of this scale.